Literature DB >> 15118167

Dementia after stroke: the Framingham Study.

Cristina S Ivan1, Sudha Seshadri, Alexa Beiser, Rhoda Au, Carlos S Kase, Margaret Kelly-Hayes, Philip A Wolf.   

Abstract

BACKGROUND AND
PURPOSE: Identification of risk factors for dementia after stroke is best performed in comparison with stroke-free controls, because older subjects at high risk for stroke also have a substantial risk of dementia in the absence of stroke. Previous case-control studies were hospital-based. We used a nested case-control design to prospectively evaluate these risk factors in the community-based Framingham Study cohort.
METHODS: We compared 212 subjects who were free of dementia in January 1982 and sustained a first stroke after this date, with 1060 age- and sex-matched, stroke- and dementia-free controls. We calculated 10-year risks of dementia (by Diagnostic and Statistical Manual of Mental Disorders, Volume IV criteria) developing in cases and controls and also estimated the hazard ratios within subgroups defined by exposure to various demographic factors (age, gender, education), stroke-related features (right or left hemisphere, stroke type, second stroke), stroke risk factors (hypertension, diabetes, atrial fibrillation, smoking) and apolipoprotein E genotype.
RESULTS: Dementia developed in 19.3% of cases and 11.0% of controls. Baseline stroke doubled the risk of dementia (hazard ratio [HR]: 2.0; 95% confidence interval [CI]: 1.5 to 3.1) and adjustment for age, sex, education, and exposure to individual stroke risk factors did not diminish the risk (HR: 2.4; 95% CI: 1.6 to 3.7). The HR was higher in younger subjects (age younger than 80 years [HR: 2.6; 95% CI: 1.5 to 4.5]), apolipoprotein E 3/3 homozygotes (HR: 3.4; 95% CI: 2.0 to 5.8), and high school graduates (HR: 2.4; 95% CI: 1.5 to 3.9).
CONCLUSIONS: Stroke increases a subject's risk of dementia as compared with age- and sex-matched controls. Primary and secondary prevention of stroke should significantly decrease the risk of all dementia.

Entities:  

Mesh:

Year:  2004        PMID: 15118167     DOI: 10.1161/01.STR.0000127810.92616.78

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  93 in total

1.  Changes in memory before and after stroke differ by age and sex, but not by race.

Authors:  Qianyi Wang; Iván Mejía-Guevara; Pamela M Rist; Stefan Walter; Benjamin D Capistrant; M Maria Glymour
Journal:  Cerebrovasc Dis       Date:  2014-03-25       Impact factor: 2.762

2.  When two are worse than one: stroke and Alzheimer disease.

Authors:  Charles S DeCarli
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

3.  Does cognition predict mortality in midlife? Results from the Whitehall II cohort study.

Authors:  Séverine Sabia; Alice Guéguen; Michael G Marmot; Martin J Shipley; Joël Ankri; Archana Singh-Manoux
Journal:  Neurobiol Aging       Date:  2008-06-09       Impact factor: 4.673

Review 4.  Pregnancy, postpartum and parity: Resilience and vulnerability in brain health and disease.

Authors:  Nicholas P Deems; Benedetta Leuner
Journal:  Front Neuroendocrinol       Date:  2020-01-24       Impact factor: 8.606

Review 5.  Vascular cognitive impairment: disease mechanisms and therapeutic implications.

Authors:  Deborah A Levine; Kenneth M Langa
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

Review 6.  Vascular risk factors and dementia: how to move forward?

Authors:  Anand Viswanathan; Walter A Rocca; Christophe Tzourio
Journal:  Neurology       Date:  2009-01-27       Impact factor: 9.910

7.  U.S. National Profile of Older Adults with Cognitive Impairment Alone, Physical Frailty Alone, and Both.

Authors:  Mei-Ling Ge; Michelle C Carlson; Karen Bandeen-Roche; Nadia M Chu; Jing Tian; Judith D Kasper; Qian-Li Xue
Journal:  J Am Geriatr Soc       Date:  2020-08-28       Impact factor: 5.562

8.  Biological and imaging predictors of cognitive impairment after stroke: a systematic review.

Authors:  Barbara Casolla; François Caparros; Charlotte Cordonnier; Stéphanie Bombois; Hilde Hénon; Régis Bordet; Francesco Orzi; Didier Leys
Journal:  J Neurol       Date:  2018-10-22       Impact factor: 4.849

Review 9.  Epidemiology of Alzheimer disease.

Authors:  Richard Mayeux; Yaakov Stern
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

10.  Vascular health, diabetes, APOE and dementia: the Aging, Demographics, and Memory Study.

Authors:  David J Llewellyn; Iain A Lang; Fiona E Matthews; Brenda L Plassman; Mary Am Rogers; Lewis B Morgenstern; Gwenith G Fisher; Mohammed U Kabeto; Kenneth M Langa
Journal:  Alzheimers Res Ther       Date:  2010-06-24       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.